Navigation Links
Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
Date:2/11/2008

e a harder time losing weight than people without diabetes; thus, finding an approach that works better than other approaches is important," says Lawrence Cheskin, M.D. F.A.C.P., director of the Johns Hopkins Weight Management Center and principal investigator of the study. "This controlled study found that a diet using portion-controlled meal replacements yielded better weight control and compliance in obese people with diabetes than prescribing standard ADA dietary recommendations."

Medifast will continually participate in studies in the future, which will add even more credibility to the Medifast Brand and Programs. For more than 25 years Medifast has been prescribed by practitioners as a safe and effective program that yields significant results and has been proven to provide significant weight loss of 2-5 pounds per week.

"Over 15,000 physicians have recommended Medifast since 1980 and millions of consumers have realized the health and wellness benefit of our program," says Michael S. McDevitt, Chief Executive Officer, Medifast, Inc. "The publication of this study adds to Medifast's already stellar reputation in the medical community."

MED-G

About Medifast:

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) national network of physicians, 3) medical
'/>"/>

SOURCE Medifast, Inc.
Copyright©2008 PR Newswire.
All rights reserved

6

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Medifast, Inc. Announces Acceptance for Publication of Clinical Efficacy Study
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Aspirin Named 8th World Wonder by Majority of Americans
6. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
7. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
8. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
11. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, Systemic Lupus ... Market Forecasts to 2015 ,, ... Lupus Erythematosus - Drug Pipeline Analysis ... Summary ,, GlobalData, the ...
(Date:12/15/2009)... December 15 EnzySurge Ltd.,(EnzySurge), a ... chronic,wound management market, announced today that it ... Drug Administration (FDA) to market its new,SilverStream(TM) ... cleared,DermaSept, an Over-the-Counter version of the SilverStream ... is the developer of the DermaStream(R) product ...
(Date:12/15/2009)... 15 NxStage Medical, Inc. (Nasdaq: ... products, today announced that a group of its ... embarking on a week-long, conventional (non-dialysis) Caribbean cruise ... cruise, dubbed the "2010 Freedom Cruise: We,re Taking ... on January 3, 2010 and returns on January ...
Breaking Medicine Technology:Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 1Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 2Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 3Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 4Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 5Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 6Air Methods Reports 3Q2009 Results and 4Q2009 Update 6031 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 1InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 2InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 3InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 4InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 6InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 8InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 9InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 10InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 11InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 12InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 13PDI Reports 2009 Third Quarter Financial Results 6023 1PDI Reports 2009 Third Quarter Financial Results 6023 2PDI Reports 2009 Third Quarter Financial Results 6023 3PDI Reports 2009 Third Quarter Financial Results 6023 4PDI Reports 2009 Third Quarter Financial Results 6023 5PDI Reports 2009 Third Quarter Financial Results 6023 6PDI Reports 2009 Third Quarter Financial Results 6023 7PDI Reports 2009 Third Quarter Financial Results 6023 8PDI Reports 2009 Third Quarter Financial Results 6023 9PDI Reports 2009 Third Quarter Financial Results 6023 10PDI Reports 2009 Third Quarter Financial Results 6023 11
... BALTIMORE, Dec. 10 Data by Dr. J. Bart Classen ... Research & Reviews provides further evidence that epidemics of ... to immunization. Classen previously published proof vaccines are causing an ... , The new data as well ...
... results from a Phase 1/2 study of perifosine in ... relapsed from or refractory to bortezomib , ... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) today ... in combination with bortezomib (+/- dexamethasone) in patients with ...
Other Medicine Technology:Epidemics of Both Type 1 Diabetes (Insulin Dependent) and Type 2 Diabetes (Obesity Related) Are Linked to Immunization 2Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 7
(Date:12/15/2009)... infectious HIV-1 is widely thought to be the major ... persons. U.S. Military HIV Research Program (MHRP) researchers, however, ... particles can bind to the surface of red blood ... donors. The results were published today in PLoS ... The lead investigators, Dr. Zoltan Beck and Dr. Carl ...
(Date:12/15/2009)... how to make an AIDS vaccine have found the ... the immune system can indeed produce cells with the ... the same time, the immune system works equally hard ... have a chance to mature. , "These studies show ... disease is under the control of immunological tolerance," said ...
(Date:12/15/2009)... users to control the volume without compromising sound-quality or comfort. ... ... 15, 2009 -- EarPeace ( www.earpeace.com ) is redefining hearing ... in three different skin-tone colors. "As a big fan of ... I was looking for a way to continue my active ...
(Date:12/15/2009)... Management Systems (HRMS), announced in a direct response to demand ... (APSS) to its suite of HR software, to increase productivity ... ... Mahwah, NJ (PRWEB) December 15th 2009 -- Humanic ... announced in a direct response to demand for increased technology ...
(Date:12/15/2009)... Better mental health care still needed for those with ... News) -- Suicides among people in Switzerland who were ... the introduction of highly active antiretroviral therapy in 1996, ... that causes AIDS. , Yet despite the decrease, the ... higher than that of the general population, according to ...
Breaking Medicine News(10 mins):Health News:Biological catch-22 prevents induction of antibodies that block HIV 2Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2Health News:Humanic Design is Pleased to Announce Application Self Service (APSS) to its Product Suite to Empower Organizations with Automation 2Health News:HIV Therapy Linked to Fewer Suicides 2
... 50 are more likely to die from suicide than any ... ,A study of public hospital emergency departments in Perth ... the emergency departments of seven Perth hospitals between June 2000 ... suicide within weeks of being discharged. The sample included terminally ...
... organisms, are exposed to ever-changing environments, oxidative stress, ... to defend themselves against all these insults, gain ... simply by ‘stealing’ genetic information from other better-adapted ... sex, known as horizontal gene transfer. ...
... Central Bureau of Investigation (CBI) carried out simultaneous raids ... Delhi and three other cities on Monday.// ,The ... the national capital, an official of the investigating agency ... Safdarjung Hospital's gynaecology department, and Uma Goel of Sucheta ...
... can cure tumors in animals and humans.,Scientists led by Moira ... an aggressive //form of brain cancer after finding the method ... of the herpes virus was injected into the patient who ... But, eight years later he is still alive and his ...
... Hospitals Group plans to invest Rs 350 crore to add ... new addition of 1800 beds, Apollo Group's total capacity would ... ,"There is a plan for adding 800 beds through management ... Hospitals Group Director Finance, Suneeta Reddy, said here on the ...
... that can lead to a multitude of complications if ... suggests the possibility of using tea as a form ... has been found to prevent the incidence of cataracts, ... diabetics worldwide. , ,Researchers developed special rats with ...
Other Medicine News:Health News:Bacteria Evolve Armamentarium Against Antibiotics By ‘Stealing’ Gen 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: